Murat Ayhan
- Specialization: Clinical oncologist
- 12 years of experience
- Speaks:English
- Online consultations: available
- Workplace: Turkey, Istanbul, Liv Hospital Vadistanbul
- Member of the European Society for Medical Oncology (ESMO) and principal investigator in global Phase II and III oncology clinical trials.
Dr. Murat Ayhan is an associate professor of medical oncology at Liv Hospital Vadistanbul. He is an expert in treating breast, lung, colorectal, and urogenital cancers. Dr. Ayhan focuses on immunotherapy and targeted therapies. He provides personalized care for patients with adenocarcinoma and osteosarcoma. Dr. Ayhan works at a JCI-accredited facility in Istanbul.
- Principal investigator in global Phase II and III clinical oncology trials.
- Active member of the European Society for Medical Oncology (ESMO).
- Published over 25 articles in international scientific journals.
- Authored medical book chapters on tyrosine kinase inhibitors and oncology emergencies.
Online consultation with Murat Ayhan
Patient reviews
Doctor's services
How are we doing?
Qualifications
Dr. Murat Ayhan is an Associate Professor of Medical Oncology at Liv Hospital Vadistanbul. He treats patients using immunotherapy and targeted drugs for cancers. He is a principal investigator for global Phase II and III clinical trials.
Oncology Specialization
Dr. Ayhan treats a wide range of solid tumors. He helps patients with breast, lung, and colorectal cancers. He also treats gynecological and urogenital malignancies. He uses molecular oncology to create treatment plans for each patient. His methods include:
- Immunotherapy
- Targeted Therapy
- Hormone therapy
- Chemotherapy
- Rapid drug desensitization – a method to safely give medication to patients who have had allergic reactions
Clinical Research and Trials
Dr. Ayhan leads international studies to improve cancer care. He investigates new therapies for metastatic breast and lung cancers. His work includes research on drugs such as Atezolizumab and Palbociclib. He studied how COVID–19 affects cancer patient mortality. Additionally, he researches PET/CT imaging to predict chemotherapy success.
Work Experience
- Liv Hospital Vadistanbul
- Adıyaman University Training and Research Hospital
- Istanbul Umraniye Training and Research Hospital
Education and Academic Background
- 2007 – Dicle University, Faculty of Medicine – Medical Degree
- 2014 – Istanbul Medeniyet University Göztepe Hospital – Residency
- 2021 – Kartal City Hospital – Specialized Oncology Training
- 2023 – Associate Professor of Medical Oncology
Publications and Authorship
Dr. Ayhan has published 25 articles in international journals. He also authors chapters in oncology reference books. Notable works include:
- "Small molecule tyrosine kinase inhibitors" in Turkish Clinics Journal (2021)
- "Oncological emergencies" in Internal Medicine Emergencies (2022)
- "Medical approach in primary non-gastrointestinal neuroendocrine tumors" (2020)
- "Survival analysis of patients with triple-negative breast cancer" (2022)
Professional Memberships
- European Society for Medical Oncology (ESMO)
- Turkish Society of Medical Oncology (TTOD)
You may also be interested
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.